Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (291-300 of 350) with videos related to

Pageof 35
Sort By:
JAMA Oncology|April 3, 2025
Chromosome 1p Loss and 1q Gain for Grading of MeningiomaAlexander P Landry, Justin Z Wang, Vikas Patil, et al.
Nature Communications|September 4, 2019
YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesisKristian W Pajtler, Yiju Wei, Konstantin Okonechnikov, et al.
Brain Pathology (Zurich, Switzerland)|April 21, 2020
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and gradingDavid N Louis, Pieter Wesseling, Kenneth Aldape, et al.
JAMA Network Open|April 11, 2025
Practice Variation in Perioperative Dexamethasone Use and Outcomes in Brain Metastasis ResectionDavid Wasilewski, Tommaso Araceli, Artem Rafaelian, et al.
Acta Neuropathologica|May 17, 2018
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic featuresMaximilian Y Deng, Martin Sill, Jason Chiang, et al.
Scientific Reports|July 12, 2019
New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-XLorena Favaro Pavon, David Capper, Tatiana Tais Sibov, et al.
Acta Neuropathologica|February 14, 2013
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutationsDavid E Reuss, Rosario M Piro, David T W Jones, et al.
Neuropathology and Applied Neurobiology|August 17, 2022
Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour typesAnnekathrin Reinhardt, Kristin Pfister, Daniel Schrimpf, et al.
Acta Neuropathologica|June 29, 2019
Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1Philipp Sievers, Romain Appay, Daniel Schrimpf, et al.
Neuro-Oncology|December 23, 2024
VGLL fusions define a new class of intraparenchymal central nervous system schwannomaSimone Schmid, Kanish Mirchia, Anna Tietze, et al.
Pageof 35

Showing results (291-300 of 350) with videos related to

Sort By:
Pageof 35
JAMA Oncology|April 3, 2025
Chromosome 1p Loss and 1q Gain for Grading of MeningiomaAlexander P Landry, Justin Z Wang, Vikas Patil, et al.
Nature Communications|September 4, 2019
YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesisKristian W Pajtler, Yiju Wei, Konstantin Okonechnikov, et al.
Brain Pathology (Zurich, Switzerland)|April 21, 2020
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and gradingDavid N Louis, Pieter Wesseling, Kenneth Aldape, et al.
JAMA Network Open|April 11, 2025
Practice Variation in Perioperative Dexamethasone Use and Outcomes in Brain Metastasis ResectionDavid Wasilewski, Tommaso Araceli, Artem Rafaelian, et al.
Acta Neuropathologica|May 17, 2018
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic featuresMaximilian Y Deng, Martin Sill, Jason Chiang, et al.
Scientific Reports|July 12, 2019
New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-XLorena Favaro Pavon, David Capper, Tatiana Tais Sibov, et al.
Acta Neuropathologica|February 14, 2013
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutationsDavid E Reuss, Rosario M Piro, David T W Jones, et al.
Neuropathology and Applied Neurobiology|August 17, 2022
Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour typesAnnekathrin Reinhardt, Kristin Pfister, Daniel Schrimpf, et al.
Acta Neuropathologica|June 29, 2019
Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1Philipp Sievers, Romain Appay, Daniel Schrimpf, et al.
Neuro-Oncology|December 23, 2024
VGLL fusions define a new class of intraparenchymal central nervous system schwannomaSimone Schmid, Kanish Mirchia, Anna Tietze, et al.
Pageof 35